Corcept Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Corcept Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Corcept Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Corcept Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Corcept Therapeutics Inc (Corcept) discovers, develops, and commercializes drugs for the treatment of severe metabolic and psychiatric disorders. The company’s proprietary technology, cortisol modulation, leads to the product Korlym, and its focus on other pipeline products is its major strength, even as reliance on third parties is a cause for concern to the company. Regulatory approvals, a positive outlook for the global pharmaceutical markets, and the growing ALS market provide growth opportunities for the company. However, intense competition, regulatory compliance, and uncertain R&D outcomes could affect the company's business prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer